Physician profile

Karyn-Anne B Cumberbatch

Obstetrics & Gynecology · Missouri City, TX

NPI 1073618344

$451,933.62

in general payments reported to CMS, 2019-2025

7 companies · $130K in 2025

The $130K reported for 2025 was more than what 99% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).

See the full distribution for Obstetrics & Gynecology

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Consulting Fee$263,682.04
Travel and Lodging$313.45

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Csl Plasma INC. $260,707.04 2024-2025
Csl Behring $187,799.96 2020-2022
Eli Lilly and Company $3,288.45 2025
Duchesnay USA Incorporated $121.36 2019
Lupin INC. $16.81 2019

2 companies reported research payments only; those appear in the research section below.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Karyn-Anne B Cumberbatch

$451,933.62

in general payments reported 2019-2025

Years
2019-2025
Top company
Csl Plasma INC.
Context
The $130K reported for 2025 was more than what 99% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).

https://glasscript.com/doctor/2892/karyn-anne-b-cumberbatch

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.